- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Medical Systems
Sectra Imtec provides Philips with its core image management technology. In place since 1997, the partnership led last year to the introduction of Philips IT system Vequion, which works seamlessly with ViewForum workstations.EasyAccess PACS, release
Sectra Imtec provides Philips with its core image management technology. In place since 1997, the partnership led last year to the introduction of Philips IT system Vequion, which works seamlessly with ViewForum workstations.
- EasyAccess PACS, release 10, achieves the performance of a client-based PACS with the flexibility of a Web-based system. An enhanced integrated Web client enables access from outside the hospital firewall, with all the required security for operation in the public domain.
- Enhancements to the ViewForum workstation include clinical applications and x-ray domain features. Ortho Specialist allows operators to reconstruct and view images of the legs and spine. Other features include Endo3D Specialist, providing virtual endoscopy functionality; 3D Advanced Segmentation, allowing removal or selection of specific areas of interest; and 3D Vascular Analysis, a blood vessel analysis and measurement tool.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
